30 related articles for article (PubMed ID: 38513128)
1. Efficacy of LSVT LOUD
Choi YNC; Martel-Sauvageau V; Breton M; Lavoie M; Laforce R; Bouvier L
Brain Sci; 2024 Apr; 14(5):. PubMed ID: 38790396
[TBL] [Abstract][Full Text] [Related]
2. Progression of voice and speech impairment in the course of Parkinson's disease: a longitudinal study.
Skodda S; Grönheit W; Mancinelli N; Schlegel U
Parkinsons Dis; 2013; 2013():389195. PubMed ID: 24386590
[TBL] [Abstract][Full Text] [Related]
3. Acoustical and Perceptual Analysis of Voice in Individuals with Parkinson's Disease.
Abraham EA; Geetha A
Indian J Otolaryngol Head Neck Surg; 2023 Jun; 75(2):427-432. PubMed ID: 37275077
[TBL] [Abstract][Full Text] [Related]
4. Acoustic and Perceptual Consequences of Speech Cues for Mandarin Speakers With Parkinson's Disease.
Hsu SC; McAuliffe MJ; Lin P; Wu RM; Levy ES
Am J Speech Lang Pathol; 2019 May; 28(2):521-535. PubMed ID: 31136238
[TBL] [Abstract][Full Text] [Related]
5. Crowdsourced Perceptual Ratings of Voice Quality in People With Parkinson's Disease Before and After Intensive Voice and Articulation Therapies: Secondary Outcome of a Randomized Controlled Trial.
McAllister T; Nightingale C; Moya-Galé G; Kawamura A; Ramig LO
J Speech Lang Hear Res; 2023 May; 66(5):1541-1562. PubMed ID: 37059078
[TBL] [Abstract][Full Text] [Related]
6. The Effects of Intensive Voice Treatment in Mandarin Speakers With Parkinson's Disease: Acoustic and Perceptual Findings.
Hsu SC; Jiao Y; Berisha V; McAuliffe MJ; Lin P; Wu RM; Cheng SJ; Levy ES
Am J Speech Lang Pathol; 2022 May; 31(3):1354-1367. PubMed ID: 35394803
[TBL] [Abstract][Full Text] [Related]
7. The Effects of Intensive Speech Treatment on Conversational Intelligibility in Spanish Speakers With Parkinson's Disease.
Moya-Galé G; Goudarzi A; Bayés À; McAuliffe M; Bulté B; Levy ES
Am J Speech Lang Pathol; 2018 Feb; 27(1):154-165. PubMed ID: 29351354
[TBL] [Abstract][Full Text] [Related]
8. Treating disordered speech and voice in Parkinson's disease online: a randomized controlled non-inferiority trial.
Constantinescu G; Theodoros D; Russell T; Ward E; Wilson S; Wootton R
Int J Lang Commun Disord; 2011; 46(1):1-16. PubMed ID: 21281410
[TBL] [Abstract][Full Text] [Related]
9. ¿Notas La Diferencia? [Do You Hear the Difference?]: Perceptual Consequences of Intensive Voice Treatment in Spanish Speakers With Parkinson's Disease.
Moya-Galé G; Hernández JD; Goudarzi A; Walsh SJ
J Speech Lang Hear Res; 2024 Mar; ():1-21. PubMed ID: 38513128
[TBL] [Abstract][Full Text] [Related]
10. Hypokinetic Dysarthria in Parkinson's Disease: A Narrative Review.
Atalar MS; Oguz O; Genc G
Sisli Etfal Hastan Tip Bul; 2023; 57(2):163-170. PubMed ID: 37899809
[TBL] [Abstract][Full Text] [Related]
11. PD Check-In: The development and trial of a supported self-management program for people with Parkinson's disease following intensive speech intervention.
Finnimore A; Theodoros D; Rumbach AF
Int J Lang Commun Disord; 2022 Jan; 57(1):138-151. PubMed ID: 34767290
[TBL] [Abstract][Full Text] [Related]
12. Effects of intensive speech treatment on Mandarin speakers with Parkinson's Disease: A review.
Chen Q; Chen B; Wan Q; Wang Y; Li J; Huang Z
Medicine (Baltimore); 2023 Feb; 102(6):e32900. PubMed ID: 36820601
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
